Fundraising Fox

Aptose Biosciences Inc.

Del Mar, US · 1 known investors

Find your way into Aptose Biosciences Inc.

Aptose Biosciences is a biopharmaceutical company developing novel cancer therapeutics, with a focus on acute myeloid leukemia treatments. The company is advancing tuspetinib through clinical trials for AML indications.

BiotechHealthtechMedical Devices

Investors · 1

Venture OntarioToronto

In the news

(APS) Pivots Trading Plans and Risk Controls (APS:CA) - Stock Traders Daily Canadacanada.stocktradersdaily.com · Sep 2026Aptose Biosciences Inc. announced that it expects to receive $25 million in funding -February 06, 2025 | MarketScreenermarketscreener.com · Feb 2025

Frequently asked questions

What does Aptose Biosciences Inc. do?
Aptose Biosciences is a biopharmaceutical company developing novel cancer therapeutics, with a focus on acute myeloid leukemia treatments. The company is advancing tuspetinib through clinical trials for AML indications.
Who are Aptose Biosciences Inc.'s investors?
Aptose Biosciences Inc.'s investors include Venture Ontario.
Where is Aptose Biosciences Inc. headquartered?
Aptose Biosciences Inc. is headquartered in Del Mar, US.